Sonal Tuli, MD
Ophthalmology · Gainesville, FLNPI 1114955796
Payments from drug & device makers
Across 22 payments — averaging $2762.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kowa Research Institute, Inc.$47K
- Recordati_rare_diseases_inc.$11K
- Ocular Therapeutix, Inc.$2K
- Dompe US, Inc.$104
- Alcon$79
- Novartis$63
- plus $56 from 1 others
What the payments were for
- Consulting fees$1,95085%
- Food & beverage$33815%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kowa Research Institute, Inc. | 9 | $47,046 |
| Recordati_rare_diseases_inc. | 5 | $11,440 |
| Ocular Therapeutix, Inc. | 2 | $1,987 |
| Dompe US, Inc. | 1 | $104 |
| Alcon | 2 | $79 |
| Novartis | 2 | $63 |
| Cortigent Inc | 1 | $56 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$60,775 in reported general payments places this provider in the 90th percentile of 1,405 ophthalmology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 58 | $55,009 |
| Pred FortePrednisolone Acetate | 36 | $10,033 |
| CequaCyclosporine | 16 | $9,158 |
| Loteprednol Etabonate | 49 | $7,235 |
| TobradexTobramycin/Dexamethasone | 15 | $6,720 |
| Prednisolone Acetate | 155 | $5,681 |
| MoxifloxacinMoxifloxacin Hcl | 154 | $2,992 |
| Famciclovir | 12 | $1,709 |
| Fluorometholone | 15 | $1,203 |
| Ketorolac Tromethamine | 58 | $1,178 |
| ValacyclovirValacyclovir Hcl | 25 | $1,068 |
| Latanoprost | 53 | $957 |
| Timolol Maleate | 52 | $930 |
| Dexamethasone Sodium Phosphate | 18 | $614 |
| Atropine Sulfate | 15 | $405 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Gainesville
- Christine KayGainesville$1.6M
- David EichenbaumSt Petersburg$34.4M
- Robert RadenDelray Beach$7.8M
- Carl DanzigPompano Beach$5.3M
- Bruce SegalDelray Beach$4.7M
- Cathleen McCabeBradenton$4.6M
- Ivan SunerTampa$3.7M
- Sunir JoshiFt Lauderdale$3.7M
- Harold BrooksTallahassee$3.5M
- Matthew CunninghamOrlando$2.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.